Key facts
- This page summarizes 22NW, LP's Form 4 filing for STRATA Skin Sciences, Inc. (SSKN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Aug 2023, 16:34.
22NW, LP - 16 Aug 2023 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- SSKN
- Reported as of
- 16 Aug 2023
- Net transaction value
- +$1,023,072
- SEC form
- 4
- Accepted by SEC
- 18 Aug 2023, 16:34:57 UTC
- Prior SEC filing
- 04 May 2022
- Source filing
- View source filing
- Reporting owner signature
- 22NW Fund, LP; By: 22NW Fund GP, LLC; By: /s/ Aron R. English, Manager
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
22NW, LP filed Form 4 for STRATA Skin Sciences, Inc. (SSKN) on 18 Aug 2023.
Change
- Previous filing in this sequence was filed on 04 May 2022.
- Current net transaction value: +$1,023,072.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SSKN
transaction
Common Stock
Purchase
- Transaction value
- $1,023,072
- Shares
- +1,853,056
- Change %
- +53%
- Price
- $0.5521
- Shares after
- 5,369,954
- Date
- 16 Aug 2023
- Ownership
- By: 22NW Fund, LP
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron R. English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Footnote F2
Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4799 to $0.5600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F3
Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.